Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Clinical trial NCT04067414 · COMPLETED

Trial details

NCT number: NCT04067414
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma High-grade B-cell Lymphoma Transformed Lymphoma Primary Mediastinal Large B Cell Lymphoma

Start date: 2018-06-08
Primary completion: 2021-06-04
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.